真实译文展示（如有保密内容均以XX代替）
Real translation show (All confidential contents are replaced with XX)
 
 
上海市生物医药产业促进中心成立于2021年8月，是上海市经济和信息化委员会直属事业单位，是落实上海市生物医药产业发展领导小组和上海市生物医药产业推进工作专班目标任务的办事机构。
Established in August 2021, Shanghai Biopharma Industry Promotion Center (the Center) is a public institution directly under the Shanghai Municipal Commission of Economy and Informatization. It serves as an agency that carries out the goals and the tasks of Shanghai Biopharma Industry Development Leading Group and Shanghai Biopharma Industry Promotion Special Group.
 
中心根据上海市委和市政府关于生物医药产业发展规划和战略部署，以促进上海生物医药产业高质量发展为使命，打造具有全球影响力的生物医药产业高地和产业集群。
Following the development plan and strategic deployment of the Shanghai Municipal Party Committee and Municipal Government on the biopharma industry, the Center is committed to building a hub and cluster of biopharma industry with global influence under the mission of promoting a high-quality biopharma industry development in Shanghai.
 
中心主要职能：
Main functions of the Center:
 
一、发挥智库作用，开展生物医药产业发展政策研究、行业运行分析、产业数据采集和产业信息库建设，为政府部门决策提供依据；参与编制上海市生物医药产业发展战略及发展规划，协助政府部门拟定相关政策、措施和法规，并组织实施。开展各类软课题研究，撰写年度生物医药产业报告。
I. Fully leverage think-tanks to provide a decision-making basis for government departments by carrying out development policy research, operation analysis, data collection and information base construction of the biopharma industry. Participate in the formulation of development strategies and plans of the biopharma industry for Shanghai, assist government departments in formulating relevant policies, measures and regulations, and organize the implementation. Carry out all kinds of soft subject research and draft annual reports on the biopharma industry.
 
二、架设政府和企业桥梁，为企业做好全方位服务，包括人才服务、成果转化服务、产医融合服务、金融服务、第三方公共服务等。加强产业技能及产业人才培训，积极引进创新成果和高层次人才；探索实施“临床加速器”、企业“批次贷”、“产业链贷”等服务内容。
II. Build a bridge between the government and enterprises, and provide all-round services including talent services, achievement transformation services, industry-medicine integration services, financial services, third-party public services and such for enterprises. Strengthen the training of skills and personnel within the biopharma industry, and actively introduce innovative achievements and high-level talents. Explore the provision of services such as “clinical trial accelerator”, “multi-tranche financing facility” (for enterprises), “industrial chain loan”, and more.